Advertisement

Topics

TARIS Biomedical LLC Company Profile

03:43 EDT 20th June 2018 | BioPortfolio

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new treatments for millions of patients suffering from difficult-to-treat bladder diseases. We are advancing therapies for debilitating conditions, including bladder cancer and overactive bladder, enabled by continuous local dosing where it is needed. www.tarisbiomedical.com


News Articles [272 Associated News Articles listed on BioPortfolio]

Yonghua Capital Leads $25 Million B Round in Taris Biomedical

Shanghai's Yonghua Capital, a private equity investor with an interest in life science, led a $25 million Series B funding in Taris Biomedical. Taris is a Boston-area company that is developing implan...

TARIS ® to Present at Cowen Health Care Conference

TARIS announced that CEO Purnanand Sarma is presenting today, March 12th, at the Cowen and Company 38th Annual Health Care Conference from 8:30-8:55 a.m. ET in the Northeas...

TARIS to begin Phase lb trial of TAR-200 and Opdivo combination

TARIS Biomedical has partnered with Bristol-Myers Squibb to undertake a Phase lb clinical trial of TAR-200 (GemRIS) in combination with...Read More... The post TARIS to begin Phase lb trial of TAR-200...

Taris and BMS team up for Phase I trial in bladder cancer

Taris Biomedical LLC agreed to conduct a combination clinical trial of its TAR200 (GemRIS) with Bristol-Myers Squibb Co.'s Opdivo (nivolumab) in muscle-invasive bladder cancer patients who are schedul...

TARIS® Announces Late-Breaking Poster Presentation at American Association of Cancer Research Annual Meeting

TARIS today announced that it will present a late-breaking poster related to TAR-200 (GemRIS™), the company’s lead clinical program in bladder cancer, at the upcoming A...

U.S. FDA Grants Fast Track Designation to TARIS® for TAR-200 (GemRIS™) in Muscle Invasive Bladder Cancer

Designation for Patients Unfit for Curative Intent Therapy TARIS today announced that the United States Food and Drug Administration (FDA) has granted Fast Track design...

TARIS® Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent Therapy

TARIS announced today that it has initiated dosing in a clinical trial of TAR-200 (GemRIS™) in patients with Muscle Invasive Bladder Cancer (MIBC) who are unfit for thera...

Drug delivery company Taris raises $25M series B

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Zorbtive [EMD Serono, Inc.]

Zorbtive [somatropin (rDNA origin) for injection]

Fludeoxyglucose [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f18 [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Serostim [EMD Serono, Inc.]

Serostim [somatropin (rDNA origin) for injection]

PubMed Articles [329 Associated PubMed Articles listed on BioPortfolio]

DataMed - an open source discovery index for finding biomedical datasets.

Finding relevant datasets is important for promoting data reuse in the biomedical domain, but it is challenging given the volume and complexity of biomedical data. Here we describe the development of ...

Exploiting Semantic Patterns over Biomedical Knowledge Graphs for Predicting Treatment and Causative Relations.

Identifying new potential treatment options for medical conditions that cause human disease burden is a central task of biomedical research. Since all candidate drugs cannot be tested with animal and ...

New JBI policy emphasizes substantive, practical methodological innovations for biomedical privacy and security papers.

A Hybrid Model Based on Neural Networks for Biomedical Relation Extraction.

Biomedical relation extraction can automatically extract high-quality biomedical relations from biomedical texts, which is a vital step for the mining of biomedical knowledge hidden in the literature....

Assessing the Practice of Biomedical Ontology Evaluation: Gaps and Opportunities.

With the proliferation of heterogeneous health care data in the last three decades, biomedical ontologies and controlled biomedical terminologies play a more and more important role in knowledge repre...

Clinical Trials [104 Associated Clinical Trials listed on BioPortfolio]

Safety and Tolerability Study of the Taris Placebo System

The aim of this protocol is to evaluate the tolerability of the Taris placebo system for the development program and to provide key safety and tolerability data for the Taris platform.

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

The aim of this study is the establishment of a warehouse physiological data and biomedical signal in intensive care adult patients in acute situations from particular records from the Phi...

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

This study will evaluate the effectiveness of community-level behavioral and biomedical interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually transmitte...

Companies [599 Associated Companies listed on BioPortfolio]

TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new treatments for millions of patients suffering from difficult-to-treat ...

Bristol-Myers Squibb and TARIS Biomedical LLC

TARIS Biomedical® is building a unique therapeutically-focused urology company, developing targeted new therapies for millions of patients suffering from difficult-to-treat ...

TARIS Biomedical

TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device converge...

TARIS Biomedical LLC and Uppsala Clinical Research Center

UCR’s mission is to improve human health in Sweden and worldwide. UCR has the competence and technology necessary to transform innovative ideas into translational research pr...

Quertle, LLC

Quertle is a biomedical search engine focused on delivering informative results to biomedical researchers using advanced linguistic technologies, along with an in-depth und...

More Information about "TARIS Biomedical LLC" on BioPortfolio

We have published hundreds of TARIS Biomedical LLC news stories on BioPortfolio along with dozens of TARIS Biomedical LLC Clinical Trials and PubMed Articles about TARIS Biomedical LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TARIS Biomedical LLC Companies in our database. You can also find out about relevant TARIS Biomedical LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record